{"id":77166,"date":"2025-09-10T03:06:51","date_gmt":"2025-09-10T01:06:51","guid":{"rendered":"https:\/\/www.cdj-bouffort.com\/?p=77166"},"modified":"2026-01-30T13:25:35","modified_gmt":"2026-01-30T12:25:35","slug":"pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty","status":"publish","type":"post","link":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/","title":{"rendered":"Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty"},"content":{"rendered":"<h2>\u00davod do pr\u00e1vnych noriem v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov<\/h2>\n<p>Legislat\u00edva a regul\u00e1cie v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov zohr\u00e1vaj\u00fa k\u013e\u00fa\u010dov\u00fa rolu v zabezpe\u010den\u00ed kvality a bezpe\u010dnosti liekov pre pacientov. Tieto pr\u00e1vne predpisy s\u00fa navrhnut\u00e9 tak, aby chr\u00e1nili ob\u010danov a zaru\u010dili dodr\u017eiavanie etick\u00fdch \u0161tandardov pri poskytovan\u00ed zdravotnej starostlivosti.<\/p>\n<p>V r\u00e1mci st\u00e1tn\u00ed kontroly sa sledovanie farmaceutick\u00fdch produktov vykon\u00e1va prostredn\u00edctvom pr\u00edsnych regul\u00e1ci\u00ed, ktor\u00e9 zabezpe\u010duj\u00fa, \u017ee v\u0161etky lieky absolvuj\u00fa klinick\u00e9 testovanie s cie\u013eom overi\u0165 ich bezpe\u010dnos\u0165 a efekt\u00edvnos\u0165. T\u00fdmto sp\u00f4sobom sa predch\u00e1dza ne\u017eiaducim \u00fa\u010dinkom a zabezpe\u010duje sa zodpovednos\u0165 v\u00fdrobcov za kvalitu ich produktov.<\/p>\n<p>Pacienti maj\u00fa pr\u00e1vo na inform\u00e1cie o liekoch, ktor\u00e9 u\u017e\u00edvaj\u00fa, a preto je dodr\u017eiavanie predpisov v oblasti lek\u00e1rn\u00ed nevyhnutn\u00e9. Okrem toho, s rast\u00facim po\u010dtom generick\u00fdch liekov a internetov\u00fdch predajcov sa zvy\u0161uje potreba transparentnosti a regul\u00e1ci\u00ed v tejto oblasti. V kone\u010dnom d\u00f4sledku je etika a zodpovednos\u0165 v <a href=\"https:\/\/paxgyogyszertarhu.com\/\">https:\/\/paxgyogyszertarhu.com\/<\/a> farmaceutickej praxi z\u00e1kladom pre d\u00f4veru pacientov a zabezpe\u010duj\u00fa patologick\u00e9 v\u00fdsledky.<\/p>\n<h2>K\u013e\u00fa\u010dov\u00e9 legislat\u00edvne regul\u00e1cie ovplyv\u0148uj\u00face farmaceutick\u00fd sektor<\/h2>\n<p>Farmaceutick\u00fd sektor je neodmyslite\u013ene prepojen\u00fd s r\u00f4znymi legislat\u00edvnymi regul\u00e1ciami, ktor\u00e9 zabezpe\u010duj\u00fa, \u017ee produkty s\u00fa kvalitn\u00e9 a bezpe\u010dn\u00e9 pre pacientov. Tieto regul\u00e1cie sa zameriavaj\u00fa na dodr\u017eiavanie predpisov a etiku vo v\u0161etk\u00fdch aspektoch v\u00fdskumu a v\u00fdvoja nov\u00fdch liekov.<\/p>\n<p>Jedn\u00fdm z najd\u00f4le\u017eitej\u0161\u00edch aspektov je klinick\u00e9 testovanie, ktor\u00e9 podlieha pr\u00edsnym norm\u00e1m a \u0161t\u00e1tnym kontrol\u00e1m, \u010d\u00edm sa zabezpe\u010duje zodpovednos\u0165 vo\u010di pacientom. Kvalita liekov je zabezpe\u010den\u00e1 prostredn\u00edctvom sledovania v\u00fdrobn\u00fdch procesov a pravideln\u00fdch kontrol.<\/p>\n<p>Regul\u00e1cie tie\u017e ur\u010duj\u00fa pravidl\u00e1 pre inov\u00e1ciu a marketing farmaceutick\u00fdch produktov, \u010do zvy\u0161uje d\u00f4veru verejnosti v tieto produkty. Ochrana pr\u00e1v pacientov je prioritou, kde etika zohr\u00e1va k\u013e\u00fa\u010dov\u00fa \u00falohu vo v\u0161etk\u00fdch f\u00e1zach, od v\u00fdskumu po uvedenie na trh.<\/p>\n<p>V kone\u010dnom d\u00f4sledku legislat\u00edva a jej regul\u00e1cie formuj\u00fa prostredie, v ktorom sa farmaceutick\u00fd sektor m\u00f4\u017ee rozv\u00edja\u0165 a prispieva\u0165 k zdravstvu celej popul\u00e1cie.<\/p>\n<h2>Zabezpe\u010denie kvality a bezpe\u010dnosti farmaceutick\u00fdch v\u00fdrobkov<\/h2>\n<p>Zabezpe\u010denie kvality a bezpe\u010dnosti farmaceutick\u00fdch v\u00fdrobkov je z\u00e1kladn\u00fdm pilierom zdravotnej starostlivosti. Legislat\u00edva a regul\u00e1cie stanovuj\u00fa pr\u00edsne normy pre v\u00fdvoj, v\u00fdrobu a distrib\u00faciu liekov, \u010d\u00edm sa zabezpe\u010duje dodr\u017eiavanie predpisov na ochranu pacientov. Tento komplexn\u00fd proces zah\u0155\u0148a aj etiku, ktor\u00e1 hr\u00e1 k\u013e\u00fa\u010dov\u00fa \u00falohu pri klinickom testovan\u00ed.<\/p>\n<p>V r\u00e1mci tzv. \u0161t\u00e1tnej kontroly sa preveruj\u00fa v\u0161etky f\u00e1zy produkcie, \u010d\u00edm sa garantuje, \u017ee lieky sp\u013a\u0148aj\u00fa pr\u00edsne kvalitat\u00edvne a bezpe\u010dnostn\u00e9 \u0161tandardy. Napr\u00edklad, zahrani\u010dn\u00e9 kontroln\u00e9 org\u00e1ny pravidelne audituj\u00fa v\u00fdrobn\u00e9 z\u00e1vody a zais\u0165uj\u00fa, \u017ee na trhu sa objavuj\u00fa len produkty s jasne preuk\u00e1zanou \u00fa\u010dinnos\u0165ou a bezpe\u010dnos\u0165ou.<\/p>\n<p>Zodpovednos\u0165 v\u00fdrobcov a dod\u00e1vate\u013eov za kvalitu v\u00fdrobkov je neodmyslite\u013en\u00e1. Ak\u00e9ko\u013evek nedodr\u017eanie predpisov m\u00f4\u017ee ma\u0165 v\u00e1\u017ene n\u00e1sledky nielen pre pacientov, ale aj pre samotn\u00fdch v\u00fdrobcov, ktor\u00ed riskuj\u00fa stratu d\u00f4very a reput\u00e1cie. D\u00f4sledn\u00e9 klinick\u00e9 testovanie pred uveden\u00edm v\u00fdrobku na trh je preto nenahradite\u013en\u00e9.<\/p>\n<h2>Etick\u00e9 z\u00e1sady a dodr\u017eiavanie predpisov v lek\u00e1rskom sektore<\/h2>\n<p>Etika a dodr\u017eiavanie predpisov s\u00fa k\u013e\u00fa\u010dov\u00fdmi aspektmi v lek\u00e1rskom sektore, kde ka\u017ed\u00fd krok vpl\u00fdva na kvalitu a bezpe\u010dnos\u0165 pacientov. Legislat\u00edva a regul\u00e1cie vytv\u00e1raj\u00fa r\u00e1mec, ktor\u00fd zabezpe\u010duje, \u017ee zdravotn\u00edcki pracovn\u00edci konaj\u00fa zodpovedne a s oh\u013eadom na blaho pacientov.<\/p>\n<p>Dodr\u017eiavanie etick\u00fdch z\u00e1sad nie je len ot\u00e1zkou z\u00e1kona, ale aj mor\u00e1lnej zodpovednosti. Etick\u00e9 spr\u00e1vanie v r\u00e1mci klinick\u00e9ho testovania si vy\u017eaduje transparentnos\u0165 a s\u00fahlas pacientov, \u010d\u00edm sa posil\u0148uje d\u00f4vera v proces a v\u00fdsledky v\u00fdskumu. St\u00e1tn\u00ed kontrola zohr\u00e1va rozhoduj\u00facu \u00falohu pri zais\u0165ovan\u00ed dodr\u017eiavania t\u00fdchto predpisov, \u010do je nevyhnutn\u00e9 pre prevenciu podvodov a zneu\u017eit\u00ed.<\/p>\n<p>Poctiv\u00fd pr\u00edstup k regul\u00e1ci\u00e1m napom\u00e1ha vytv\u00e1ra\u0165 bezpe\u010dn\u00e9 prostredie pre pacientov. Napr\u00edklad, pravideln\u00e9 audity a kontroly zo strany org\u00e1nov dozerania zabezpe\u010duj\u00fa vysok\u00e9 \u0161tandardy kvality vo v\u0161etk\u00fdch aspektoch zdravotnej starostlivosti. Tak\u00e9to opatrenia chr\u00e1nia nielen pacientov, ale aj cel\u00fa komunitu poskytovate\u013eov zdravotnej starostlivosti.<\/p>\n<h2>Klinick\u00e9 testovanie: proces, v\u00fdznam a zodpovednos\u0165<\/h2>\n<p>Klinick\u00e9 testovanie je k\u013e\u00fa\u010dov\u00fdm krokom v procese v\u00fdvoja nov\u00fdch liekov a terapi\u00ed. Jeho v\u00fdznam spo\u010d\u00edva v overovan\u00ed bezpe\u010dnosti a \u00fa\u010dinnosti nov\u00fdch liekov pred ich uveden\u00edm na trh. Tento proces je pr\u00edsne regulovan\u00fd legislat\u00edvou a zah\u0155\u0148a r\u00f4zne f\u00e1zy, kde s\u00fa pacienti zapojen\u00ed do testovania, pri\u010dom dodr\u017eiavanie predpisov a etika s\u00fa na prvom mieste.<\/p>\n<p>V s\u00fa\u010dasnosti st\u00e1tn\u00ed kontrola kladie d\u00f4raz na kvalitu a bezpe\u010dnos\u0165 klinick\u00e9ho testovania. Napr\u00edklad, v\u0161etky testy musia sp\u013a\u0148a\u0165 pr\u00edsne normy, aby sa zabezpe\u010dila ochrana pacientov. Regula\u010dn\u00e9 org\u00e1ny uplat\u0148uj\u00fa pr\u00edsne kontroly, aby zabezpe\u010dili, \u017ee v\u00fdsledky testovania s\u00fa spo\u013eahliv\u00e9 a eticky spravodliv\u00e9.<\/p>\n<p>Odpovednos\u0165 za klinick\u00e9 testovanie le\u017e\u00ed na v\u00fdskumn\u00edkoch a pharmaceutick\u00fdch firm\u00e1ch, ktor\u00ed musia predch\u00e1dza\u0165 ak\u00fdmko\u013evek nepriazniv\u00fdm \u00fa\u010dinkom liekov. Je to preto, \u017ee \u00faspe\u0161n\u00e9 klinick\u00e9 testovanie prispieva nielen k zlep\u0161eniu verejn\u00e9ho zdravia, ale aj k budovaniu d\u00f4very medzi pacientmi a poskytovate\u013emi zdravotnej starostlivosti.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00davod do pr\u00e1vnych noriem v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov Legislat\u00edva a regul\u00e1cie v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov zohr\u00e1vaj\u00fa k\u013e\u00fa\u010dov\u00fa rolu v zabezpe\u010den\u00ed kvality a bezpe\u010dnosti liekov pre pacientov. Tieto pr\u00e1vne predpisy s\u00fa navrhnut\u00e9 tak, aby chr\u00e1nili ob\u010danov a zaru\u010dili dodr\u017eiavanie etick\u00fdch \u0161tandardov pri poskytovan\u00ed zdravotnej starostlivosti. V r\u00e1mci st\u00e1tn\u00ed kontroly sa sledovanie farmaceutick\u00fdch &hellip; <a href=\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[536],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty - SCP B\u00e9reng\u00e8re BOUFFORT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty - SCP B\u00e9reng\u00e8re BOUFFORT\" \/>\n<meta property=\"og:description\" content=\"\u00davod do pr\u00e1vnych noriem v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov Legislat\u00edva a regul\u00e1cie v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov zohr\u00e1vaj\u00fa k\u013e\u00fa\u010dov\u00fa rolu v zabezpe\u010den\u00ed kvality a bezpe\u010dnosti liekov pre pacientov. Tieto pr\u00e1vne predpisy s\u00fa navrhnut\u00e9 tak, aby chr\u00e1nili ob\u010danov a zaru\u010dili dodr\u017eiavanie etick\u00fdch \u0161tandardov pri poskytovan\u00ed zdravotnej starostlivosti. V r\u00e1mci st\u00e1tn\u00ed kontroly sa sledovanie farmaceutick\u00fdch &hellip; Continue reading Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/\" \/>\n<meta property=\"og:site_name\" content=\"SCP B\u00e9reng\u00e8re BOUFFORT\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T01:06:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-30T12:25:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Deleglise45\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cdj-bouffort.com\/#website\",\"url\":\"https:\/\/www.cdj-bouffort.com\/\",\"name\":\"SCP B\\u00e9reng\\u00e8re BOUFFORT\",\"description\":\"Huissier de justice\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cdj-bouffort.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/#webpage\",\"url\":\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/\",\"name\":\"Pr\\u00e1vne normy ovplyv\\u0148uj\\u00face lek\\u00e1rne a farmaceutick\\u00e9 produkty - SCP B\\u00e9reng\\u00e8re BOUFFORT\",\"isPartOf\":{\"@id\":\"https:\/\/www.cdj-bouffort.com\/#website\"},\"datePublished\":\"2025-09-10T01:06:51+00:00\",\"dateModified\":\"2026-01-30T12:25:35+00:00\",\"author\":{\"@id\":\"https:\/\/www.cdj-bouffort.com\/#\/schema\/person\/2c48253a8e4b677bf3106e3bd0832ca6\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.cdj-bouffort.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pr\\u00e1vne normy ovplyv\\u0148uj\\u00face lek\\u00e1rne a farmaceutick\\u00e9 produkty\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cdj-bouffort.com\/#\/schema\/person\/2c48253a8e4b677bf3106e3bd0832ca6\",\"name\":\"Deleglise45\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.cdj-bouffort.com\/#personlogo\",\"inLanguage\":\"fr-FR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d100ee18e6d4c7755bd430b8cf2d65ee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d100ee18e6d4c7755bd430b8cf2d65ee?s=96&d=mm&r=g\",\"caption\":\"Deleglise45\"},\"url\":\"https:\/\/www.cdj-bouffort.com\/index.php\/author\/deleglise45\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty - SCP B\u00e9reng\u00e8re BOUFFORT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/","og_locale":"fr_FR","og_type":"article","og_title":"Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty - SCP B\u00e9reng\u00e8re BOUFFORT","og_description":"\u00davod do pr\u00e1vnych noriem v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov Legislat\u00edva a regul\u00e1cie v oblasti lek\u00e1rn\u00ed a farmaceutick\u00fdch produktov zohr\u00e1vaj\u00fa k\u013e\u00fa\u010dov\u00fa rolu v zabezpe\u010den\u00ed kvality a bezpe\u010dnosti liekov pre pacientov. Tieto pr\u00e1vne predpisy s\u00fa navrhnut\u00e9 tak, aby chr\u00e1nili ob\u010danov a zaru\u010dili dodr\u017eiavanie etick\u00fdch \u0161tandardov pri poskytovan\u00ed zdravotnej starostlivosti. V r\u00e1mci st\u00e1tn\u00ed kontroly sa sledovanie farmaceutick\u00fdch &hellip; Continue reading Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty","og_url":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/","og_site_name":"SCP B\u00e9reng\u00e8re BOUFFORT","article_published_time":"2025-09-10T01:06:51+00:00","article_modified_time":"2026-01-30T12:25:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Deleglise45","Dur\u00e9e de lecture estim\u00e9e":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.cdj-bouffort.com\/#website","url":"https:\/\/www.cdj-bouffort.com\/","name":"SCP B\u00e9reng\u00e8re BOUFFORT","description":"Huissier de justice","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cdj-bouffort.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/#webpage","url":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/","name":"Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty - SCP B\u00e9reng\u00e8re BOUFFORT","isPartOf":{"@id":"https:\/\/www.cdj-bouffort.com\/#website"},"datePublished":"2025-09-10T01:06:51+00:00","dateModified":"2026-01-30T12:25:35+00:00","author":{"@id":"https:\/\/www.cdj-bouffort.com\/#\/schema\/person\/2c48253a8e4b677bf3106e3bd0832ca6"},"breadcrumb":{"@id":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.cdj-bouffort.com\/index.php\/2025\/09\/10\/pravne-normy-ovplyvnujuce-lekarne-a-farmaceuticke-produkty\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.cdj-bouffort.com\/"},{"@type":"ListItem","position":2,"name":"Pr\u00e1vne normy ovplyv\u0148uj\u00face lek\u00e1rne a farmaceutick\u00e9 produkty"}]},{"@type":"Person","@id":"https:\/\/www.cdj-bouffort.com\/#\/schema\/person\/2c48253a8e4b677bf3106e3bd0832ca6","name":"Deleglise45","image":{"@type":"ImageObject","@id":"https:\/\/www.cdj-bouffort.com\/#personlogo","inLanguage":"fr-FR","url":"https:\/\/secure.gravatar.com\/avatar\/d100ee18e6d4c7755bd430b8cf2d65ee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d100ee18e6d4c7755bd430b8cf2d65ee?s=96&d=mm&r=g","caption":"Deleglise45"},"url":"https:\/\/www.cdj-bouffort.com\/index.php\/author\/deleglise45\/"}]}},"_links":{"self":[{"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/posts\/77166"}],"collection":[{"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/comments?post=77166"}],"version-history":[{"count":1,"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/posts\/77166\/revisions"}],"predecessor-version":[{"id":77167,"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/posts\/77166\/revisions\/77167"}],"wp:attachment":[{"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/media?parent=77166"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/categories?post=77166"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cdj-bouffort.com\/index.php\/wp-json\/wp\/v2\/tags?post=77166"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}